Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginesatide Extension Study in CKD Anemia
NCT00372489Phase 2Terminated
- Sponsor
- Affymax, Inc.
- Start
- Sep 2006
- Primary completion
- Nov 2009
- Modality
- Peptides, Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of peginesatide in anemia of chronic kidney disease (CKD-A), sponsored by Affymax, Inc.. Started Sep 2006; status: terminated.
02
Drugs
peginesatide
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT00372489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00372489.